Suppr超能文献

5-苯并恶唑-2-羧酸衍生物的合成及结构活性关系研究作为新型微管蛋白聚合抑制剂。

Synthesis and structure-activity relationships of 5-phenyloxazole-2-carboxylic acid derivatives as novel inhibitors of tubulin polymerization.

机构信息

School of Biotechnology and Health Sciences, Wuyi University, Jiangmen 529020, China.

School of Biotechnology and Health Sciences, Wuyi University, Jiangmen 529020, China; International Healthcare Innovation Institute (Jiangmen), Jiangmen 529040, China.

出版信息

Bioorg Med Chem Lett. 2021 May 15;40:127968. doi: 10.1016/j.bmcl.2021.127968. Epub 2021 Mar 19.

Abstract

A series of 5-phenyloxazole-2-carboxylic acid derivatives were synthesized, and their structure-activity relationships (SARs) were studied. N,5-diphenyloxazole-2-carboxamides 6, 7, and 9, which mimicked ABT751, showed improved cytotoxicity compared with ABT751. Compound 9 exhibited the highest antiproliferative activities against Hela A549, and HepG2 cancer cell lines, with IC values of 0.78, 1.08, and 1.27 μM, respectively. Furthermore, compound 9 showed selectivity for human cancer cells over normal cells, and this selectivity was greater than those of ABT751 and colchicine. Preliminary mechanism studies suggested that compound 9 inhibited tubulin polymerization and led to cell cycle arrest at G/M phase. Molecular docking studies indicated that compound 9 bound to the colchicine binding site of tubulin. Our findings provided insights into useful SARs for further structural modification of inhibitors of tubulin polymerization.

摘要

我们合成了一系列 5-苯并恶唑-2-羧酸衍生物,并对其结构-活性关系(SAR)进行了研究。模拟 ABT751 的 N,5-二苯并恶唑-2-甲酰胺 6、7 和 9 显示出比 ABT751 更高的细胞毒性。化合物 9 对 Hela A549、HepG2 癌细胞系的增殖抑制活性最高,IC 值分别为 0.78、1.08 和 1.27 μM。此外,化合物 9 对人癌细胞的选择性高于正常细胞,且这种选择性大于 ABT751 和秋水仙碱。初步的机制研究表明,化合物 9 抑制微管蛋白聚合,并导致细胞周期停滞在 G/M 期。分子对接研究表明,化合物 9 结合到微管蛋白的秋水仙碱结合位点。我们的研究结果为进一步修饰微管蛋白聚合抑制剂提供了有用的 SAR。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验